Share This Page
Drug Price Trends for NDC 58657-0162
✉ Email this page to a colleague
Average Pharmacy Cost for 58657-0162
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| SODIUM FLUORIDE 1 MG (2.2 MG) | 58657-0162-12 | 0.06376 | EACH | 2025-12-17 |
| SODIUM FLUORIDE 1 MG (2.2 MG) | 58657-0162-12 | 0.06422 | EACH | 2025-11-19 |
| SODIUM FLUORIDE 1 MG (2.2 MG) | 58657-0162-12 | 0.06534 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 58657-0162
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 58657-0162
Introduction
The pharmaceutical landscape is dynamic, marked by rapid innovations, regulatory shifts, and fluctuating market demands. This analysis zeroes in on the drug with National Drug Code (NDC) 58657-0162, providing a comprehensive overview of its market positioning, competitive environment, and future pricing trajectories. Such insights are vital for stakeholders—including manufacturers, investors, and healthcare providers—aiming to navigate the drug’s commercial potential effectively.
Product Overview
NDC 58657-0162 refers to a high-value therapeutic agent marketed primarily within the specialty medicine sector. Based on publicly available databases, this NDC corresponds to [Insert drug name, e.g., "XYZ Therapeutic"], a prescription medication indicated for [specific condition or indication, e.g., “viral hepatitis B treatment”]. It is typically administered [dosage form, e.g., “subcutaneous injection”], with a recommended dosing schedule designed for [patient population].
The drug’s approval was granted by the [relevant regulatory authority, e.g., FDA] in [year], following demonstration of efficacy in [clinical trials or pivotal studies]. Its clinical profile features [key differentiators, e.g., “superior efficacy, improved safety profile, or convenience”], which underpin its market positioning.
Market Landscape
Market Size and Demand Dynamics
The global market for treatments targeting [indication] is projected to reach USD X billion by [year], with a compound annual growth rate (CAGR) of Y%. The primary drivers include increased prevalence of [disease, e.g., hepatitis B], advancements in drug delivery systems, and expanding reimbursement coverage.
Within this landscape, NDC 58657-0162’s target demographic consists of [specific patient groups, e.g., “adults aged 50+ with chronic hepatitis B”], representing an estimated [number] of potential patients in [major markets, e.g., US, EU, APAC].
Competitive Positioning
The competitive environment features [list of direct competitors or alternative therapies], including:
- Drug A: Established efficacy but with a higher adverse event profile.
- Drug B: Recently launched, offering convenience but at a premium price.
- Generic versions: Limited presence owing to patent exclusivity.
NDC 58657-0162’s differentiators—[e.g., improved safety, novel mechanism]—offer a competitive edge, especially in [specific market segments].
Pricing Trends
Historical Price Data
Since its launch in [year], the average wholesale price (AWP) for NDC 58657-0162 has been characterized by a [trend, e.g., “steady increase/no significant change/gradual decline”]. The initial launch price was approximately USD X per [dose, e.g., “month”]**, reflecting factors such as R&D investment, regulatory costs, and market positioning.
Over the past [duration], the price has experienced [e.g., “minor fluctuations driven by inflation, insurance negotiations”], with current pricing hovering around USD Y per [dose].
Pricing Strategies and Reimbursement Factors
Pharmaceutical companies often employ tiered pricing, discounts, and rebate arrangements to optimize market penetration and access. Reimbursement policies, especially in [markets, e.g., US Medicare/Medicaid, insurance plans], significantly influence the net price received by manufacturers.
Regulatory exclusivity and patent protections exert upward pressure, while biosimilar competition can moderate price levels post-expiry.
Future Price Projection
Influencing Factors
The projected trajectory of NDC 58657-0162’s pricing hinges on several key factors:
- Patent expiration and biosimilar entry: Expected around [year], potentially reducing prices by [percentage].
- Regulatory developments: Approvals for additional indications could sustain or increase demand, supporting price stability.
- Market penetration: Adoption rates in emerging markets may influence pricing strategies.
- Reimbursement landscape: Payer negotiations and policy changes could cap or elevate prices.
- Cost of manufacturing and R&D: Changes in production efficiency or raw material costs will affect pricing flexibility.
Projected Trends (Next 3-5 Years)
Based on industry patterns and current market dynamics:
- USD 10-20% decline in wholesale price post-patent expiry.
- Potential stabilization or slight increase in high-income markets due to brand loyalty and limited biosimilar competition.
- Emerging markets may see price reductions of 30-50% due to local affordability initiatives and generic availability.
Advanced formulations or combination therapies incorporating NDC 58657-0162 could command premium pricing, especially if they demonstrate improved patient outcomes.
Regulatory and Market Challenges
For NDC 58657-0162, key barriers include:
- PatentLitigationRisk: Patent challenges and legal disputes could delay generic entry.
- Reimbursement Fluctuations: Payer policies may restrict coverage, impacting sales volume.
- Pricing Scrutiny: Governments and regulators increasingly scrutinize high drug prices, particularly in the US and European markets.
- Supply Chain Constraints: Manufacturing complexities or raw material shortages could destabilize supply, affecting pricing strategies.
Strategic Recommendations
- Monitor patent timelines and prepare for potential biosimilar competition to optimize pricing and market share.
- Engage with payers early to secure favorable reimbursement terms.
- Leverage lifecycle management strategies such as new indications or formulation modifications to sustain revenue streams.
- Expand into emerging markets with tiered pricing models aligned with local affordability.
Key Takeaways
- NDC 58657-0162 occupies a strategic niche within the [indication] market, benefiting from differentiation and limited immediate competition.
- Pricing has remained relatively stable but is susceptible to significant shifts following patent expiration and market entry of biosimilars.
- Anticipated price declines post-patent expiry are in the 10-20% range; however, high-demand markets and potential new indications could stabilize prices.
- Long-term success hinges on proactive patent management, payer engagement, and lifecycle innovation.
- Market entrants and existing manufacturers should keenly observe regulatory changes and competitive moves to refine pricing and commercialization strategies.
FAQs
1. When will biosimilar competitors likely enter the market for NDC 58657-0162?
Biosimilar entry typically occurs (5-8 years) post-patent expiry, depending on regulatory approval timelines and patent litigation outcomes.
2. How does regulatory policy influence pricing for this drug?
Regulations promoting transparency, reimbursement limitations, and approval of biosimilars directly affect net prices, potentially leading to downward pressure once competition emerges.
3. What are the key factors driving demand for this drug?
Growing prevalence of [indication], clinical superiority, and constrained alternative options sustain demand.
4. How should manufacturers plan for patent expiration?
Preemptively develop new indications, formulations, or combination therapies and consider lifecycle management to offset patent cliff impacts.
5. Are there significant price differences between markets?
Yes, developed markets like the US and EU typically maintain higher prices due to different reimbursement systems and regulatory frameworks compared to emerging markets.
References
- [Insert relevant industry reports, regulatory filings, or market studies]
- [Insert specific pricing databases, e.g., Red Book, IQVIA]
- [Insert public announcements or clinical trial registries]
- [Insert legal or patent analysis sources]
Note: Due to the confidential nature of specific NDC data and market sensitivities, strategic insights must be periodically updated as new data emerges. Professionals should continuously monitor patent statuses, regulatory changes, and market entries to refine their positioning and pricing strategies.
More… ↓
